Last updated on October 2015

A Study to Evaluate the Safety and Pharmacokinetics of RadProtect in Healthy Volunteers

Brief description of study

This is a Phase 1, non-randomized, sequential-cohort, dose escalation, open-label study designed to evaluate the safety and tolerability of RadProtect® in healthy volunteers. This study is to be conducted at two clinical centers and in conformity with Good Clinical Practice (GCP).

Clinical Study Identifier: NCT02587442

Find a site near you

Start Over

SNBL Clinical Pharmacology Center

Baltimore, MD United States
  Connect »